Page 572 - Read Online

Page 10 of 12 Chen et al. Plast Aesthet Res 2020;7:49 I http://dx.doi.org/10.20517/2347-9264.2020.28

18. Rabago D, Patterson JJ, Mundt M, Kijowski R, Grettie J, et al. Dextrose prolotherapy for knee osteoarthritis: a randomized controlled
trial. Ann Fam Med 2013;11:229-37.
19. Glynn LG, Mustafa A, Casey M, Krawczyk J, Blom J, et al. Platelet-rich plasma (PRP) therapy for knee arthritis: a feasibility study in
primary care. Pilot Feasibility Stud 2018;4:93.
20. Mancuso P, Raman S, Glynn A, Barry F, Murphy JM. Mesenchymal stem cell therapy for osteoarthritis: the critical role of the cell
secretome. Front Bioeng Biotechnol 2019;7:9.
21. Case JM, Scopp JM. Treatment of articular cartilage defects of the knee with microfracture and enhanced microfracture techniques.
Sports Med Arthrosc Rev 2016;24:63-8.
22. Inderhaug E, Solheim E. Osteochondral autograft transplant (mosaicplasty) for knee articular cartilage defects. JBJS Essent Surg Tech
2019;9:e34.1-2.
23. Kim MK, Park JS, Jeon YM, Jeon YS. Clinical, radiological, and histological outcomes after the fibrin-matrix autologous chondrocyte
implantation for chondral lesions of the knee in patients more than 50 years old: a prospective case series with minimum 2-year follow-
up. J Orthop Surg (Hong Kong) 2020;28:2309499019893509.
24. Erickson BJ, Strickland SM, Gomoll AH. Indications, techniques, outcomes for matrix-induced autologous chondrocyte implantation
(MACI). Oper Tech Sports Med 2018;26:175-82.
25. Pers YM, Ruiz M, Noel D, Jorgensen C. Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art
and perspectives. Osteoarthritis Cartilage 2015;23:2027-35.
26. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. Minimal criteria for defining multipotent mesenchymal stromal
cells. The international society for cellular therapy position statement. Cytotherapy 2006;8:315-7.
27. Gupta PK, Das AK, Chullikana A, Majumdar AS. Mesenchymal stem cells for cartilage repair in osteoarthritis. Stem Cell Res Ther
2012;3:25.
28. Chen YC, Chen CH, Chen PL, Huang IY, Shen YS, et al. Donor site morbidity after harvesting of proximal tibia bone. Head Neck
2006;28:496-500.
29. Cotter EJ, Wang KC, Yanke AB, Chubinskaya S. Bone marrow aspirate concentrate for cartilage defects of the knee: from bench to
bedside evidence. Cartilage 2018;9:161-70.
30. Nathan S, Das De S, Thambyah A, Fen C, Goh J, et al. Cell-based therapy in the repair of osteochondral defects: a novel use for adipose
tissue. Tissue Eng 2003;9:733-44.
31. Si Z, Wang X, Sun C, Kang Y, Xu J, et al. Adipose-derived stem cells: Sources, potency, and implications for regenerative therapies.
Biomed Pharmacother 2019;114:108765.
32. Baer PC, Geiger H. Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells
Int 2012;2012:812693.
33. Pak J, Lee JH, Park KS, Park M, Kang LW, et al. Current use of autologous adipose tissue-derived stromal vascular fraction cells for
orthopedic applications. J Biomed Sci 2017;24:9.
34. De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, et al. Comparison of multi-lineage cells from human adipose tissue and
bone marrow. Cells Tissues Organs 2003;174:101-9.
35. Xu L, Liu Y, Sun Y, Wang B, Xiong Y, et al. Tissue source determines the differentiation potentials of mesenchymal stem cells: a
comparative study of human mesenchymal stem cells from bone marrow and adipose tissue. Stem Cell Res Ther 2017;8:275.
36. Heo JS, Choi Y, Kim HS, Kim HO. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow,
umbilical cord blood, placenta and adipose tissue. Int J Mol Med 2016;37:115-25.
37. Deng M, Gu Y, Liu Z, Qi Y, Ma GE, et al. Endothelial differentiation of human adipose-derived stem cells on polyglycolic acid/polylactic
acid mesh. Stem Cells Int 2015;2015:350718.
38. Lin J, Zhu Q, Huang J, Cai R, Kuang Y. Hypoxia promotes vascular smooth muscle cell (VSMC) differentiation of adipose-derived stem
cell (ADSC) by regulating mettl3 and paracrine factors. Stem Cells Int 2020;2020:2830565.
39. Edwards NJ, Stone R, Christy R, Zhang CK, Pollok B, et al. Differentiation of adipose derived stem cells to keratinocyte-like cells on an
advanced collagen wound matrix. Tissue Cell 2018;53:68-75.
40. Wada Y, Ikemoto T, Morine Y, Imura S, Saito Y, et al. The differences in the characteristics of insulin-producing cells using human
adipose-tissue derived mesenchymal stem cells from subcutaneous and visceral tissues. Sci Rep 2019;9:13204.
41. Gao S, Guo X, Zhao S, Jin Y, Zhou F, et al. Differentiation of human adipose-derived stem cells into neuron/motoneuron-like cells for
cell replacement therapy of spinal cord injury. Cell Death Dis 2019;10:597.
42. Tomita K, Madura T, Sakai Y, Yano K, Terenghi G, et al. Glial differentiation of human adipose-derived stem cells: implications for cell-
based transplantation therapy. Neuroscience 2013;236:55-65.
43. Lee RH, Kim B, Choi I, Kim H, Choi HS, et al. Characterization and expression analysis of mesenchymal stem cells from human bone
marrow and adipose tissue. Cell Physiol Biochem 2004;14:311-24.
44. Tsuji W, Rubin JP, Marra KG. Adipose-derived stem cells: implications in tissue regeneration. World J Stem Cells 2014;6:312-21.
45. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues - Superiority
of synovium as a cell source. Arthritis Rheum 2005;52:2521-9.
46. Mochizuki T, Muneta T, Sakaguchi Y, Nimura A, Yokoyama A, et al. Higher chondrogenic potential of fibrous synovium- and adipose
synovium-derived cells compared with subcutaneous fat-derived cells: distinguishing properties of mesenchymal stem cells in humans.
Arthritis Rheum 2006;54:843-53.
47. Kouroupis D, Bowles AC, Willman MA, Perucca Orfei C, Colombini A, et al. Infrapatellar fat pad-derived MSC response to inflammation